Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
COVID-19 Positive Versus Negative Complete Kawasaki Disease: A Study from the International Kawasaki Disease Registry.
Jose J, Tierney ESS, Harahsheh AS, Dahdah N, Raghuveer G, Friedman KG, Khoury M, Hicar MD, Merves SA, Dallaire F, Farid P, Manlhiot C, Runeckles K, Misra N, Portman M, Ballweg JA, Lee S, Jain SS, Harris TH, Szmuszkovicz JR, Orr W, Larios G, McCrindle BW. Jose J, et al. Among authors: szmuszkovicz jr. Pediatr Cardiol. 2023 Aug;44(6):1373-1381. doi: 10.1007/s00246-023-03109-w. Epub 2023 Feb 14. Pediatr Cardiol. 2023. PMID: 36786810 Free PMC article.
The Kawasaki Disease Comparative Effectiveness (KIDCARE) trial: A phase III, randomized trial of second intravenous immunoglobulin versus infliximab for resistant Kawasaki disease.
Roberts SC, Jain S, Tremoulet AH, Kim KK, Burns JC; KIDCARE Multicenter Study Group; Anand V, Anderson M, Ang J, Ansusinha E, Arditi M, Ashouri N, Bartlett A, Chatterjee A, DeBiasi R, Dekker C, DeZure C, Didion L, Dominguez S, El Feghaly R, Erdem G, Halasa N, Harahsheh A, Jackson MA, Jaggi P, Jain S, Jone PN, Kaushik N, Kurio G, Lillian A, Lloyd D, Manaloor J, McNelis A, Michalik DE, Newburger J, Newcomer C, Perkins T, Portman M, Romero J, Ronis T, Rowley A, Schneider K, Schuster J, Tejtel SKS, Sharma K, Simonsen K, Szmuszkovicz J, Truong D, Wood J, Yeh S. Roberts SC, et al. Contemp Clin Trials. 2019 Apr;79:98-103. doi: 10.1016/j.cct.2019.02.008. Epub 2019 Mar 3. Contemp Clin Trials. 2019. PMID: 30840903 Free article.
Low-Molecular-Weight Heparin vs Warfarin for Thromboprophylaxis in Children With Coronary Artery Aneurysms After Kawasaki Disease: A Pragmatic Registry Trial.
Manlhiot C, Newburger JW, Low T, Dahdah N, Mackie AS, Raghuveer G, Giglia TM, Dallaire F, Mathew M, Runeckles K, Pahl E, Harahsheh AS, Norozi K, de Ferranti SD, Friedman K, Yetman AT, Kutty S, Mondal T, McCrindle BW; International Kawasaki Disease Registry. Manlhiot C, et al. Can J Cardiol. 2020 Oct;36(10):1598-1607. doi: 10.1016/j.cjca.2020.01.016. Epub 2020 Jul 1. Can J Cardiol. 2020. PMID: 32621885 Clinical Trial.
Medium-Term Complications Associated With Coronary Artery Aneurysms After Kawasaki Disease: A Study From the International Kawasaki Disease Registry.
McCrindle BW, Manlhiot C, Newburger JW, Harahsheh AS, Giglia TM, Dallaire F, Friedman K, Low T, Runeckles K, Mathew M, Mackie AS, Choueiter NF, Jone PN, Kutty S, Yetman AT, Raghuveer G, Pahl E, Norozi K, McHugh KE, Li JS, De Ferranti SD, Dahdah N; International Kawasaki Disease Registry *. McCrindle BW, et al. J Am Heart Assoc. 2020 Aug 4;9(15):e016440. doi: 10.1161/JAHA.119.016440. Epub 2020 Jul 28. J Am Heart Assoc. 2020. PMID: 32750313 Free PMC article.
Comparison Between Currently Recommended Long-Term Medical Management of Coronary Artery Aneurysms After Kawasaki Disease and Actual Reported Management in the Last Two Decades.
Osborne J, Friedman K, Runeckles K, Choueiter NF, Giglia TM, Dallaire F, Newburger JW, Low T, Mathew M, Mackie AS, Dahdah N, Yetman AT, Harahsheh AS, Raghuveer G, Norozi K, Burns JC, Jain S, Mondal T, Portman MA, Szmuszkovicz JR, Crean A, McCrindle BW; International Kawasaki Disease Registry. Osborne J, et al. Among authors: szmuszkovicz jr. Pediatr Cardiol. 2021 Mar;42(3):676-684. doi: 10.1007/s00246-020-02529-2. Epub 2021 Jan 13. Pediatr Cardiol. 2021. PMID: 33439285
The NHLBI Study on Long-terM OUtcomes after the Multisystem Inflammatory Syndrome In Children (MUSIC): Design and Objectives.
Truong DT, Trachtenberg FL, Pearson GD, Dionne A, Elias MD, Friedman K, Hayes KH, Mahony L, McCrindle BW, Oster ME, Pemberton V, Powell AJ, Russell MW, Shekerdemian LS, Son MB, Taylor M, Newburger JW; MUSIC Study Investigators (Supplement 1). Truong DT, et al. Am Heart J. 2022 Jan;243:43-53. doi: 10.1016/j.ahj.2021.08.003. Epub 2021 Aug 19. Am Heart J. 2022. PMID: 34418362 Free PMC article.
Variation in Pharmacologic Management of Patients with Kawasaki Disease with Coronary Artery Aneurysms.
Selamet Tierney ES, Runeckles K, Tremoulet AH, Dahdah N, Portman MA, Mackie AS, Harahsheh AS, Lang SM, Choueiter NF, Li JS, Manlhiot C, Low T, Mathew M, Friedman KG, Raghuveer G, Norozi K, Szmuszkovicz JR, McCrindle BW; International Kawasaki Disease Registry. Selamet Tierney ES, et al. Among authors: szmuszkovicz jr. J Pediatr. 2022 Jan;240:164-170.e1. doi: 10.1016/j.jpeds.2021.08.072. Epub 2021 Aug 30. J Pediatr. 2022. PMID: 34474088
Infliximab versus second intravenous immunoglobulin for treatment of resistant Kawasaki disease in the USA (KIDCARE): a randomised, multicentre comparative effectiveness trial.
Burns JC, Roberts SC, Tremoulet AH, He F, Printz BF, Ashouri N, Jain SS, Michalik DE, Sharma K, Truong DT, Wood JB, Kim KK, Jain S; KIDCARE Multicenter Study Group. Burns JC, et al. Lancet Child Adolesc Health. 2021 Dec;5(12):852-861. doi: 10.1016/S2352-4642(21)00270-4. Epub 2021 Oct 27. Lancet Child Adolesc Health. 2021. PMID: 34715057 Free article. Clinical Trial.
42 results